Delivery Order SPE2DB20D1100-SPE2DB25FA2N8
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,312.08 firm fixed-price delivery order contract is for the supply of 4563354076 emtricitabine-tenofovir 200-300mg medication. The contract has an ultimate completion date of January 19, 2024 and does not have a set-aside designation, indicating open competition.
AmerisourceBergen holds a significant...
This federal contract award is for the delivery of various pharmaceutical products, including emtricitabine-tenofovir 200-300mg tablets, to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The total ceiling value of the delivery order is $13,786.52, and it has an ultimate completion date of January 13, 2022.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $1,223.20, is a Firm Fixed Price Delivery Order with a performance period through January 23, 2025. The award is for the supply of emtricitabine-tenofovir 200-300mg medication. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,116.81 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. The award has an ultimate completion date of August 28, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,672.26 to provide 4,563,918,225 units of the pharmaceutical product emtricitabine-tenofovir 200-300 mg. The contract has a period of performance through March 12, 2024 and was not set aside for any specific socioeconomic program. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) on September 10, 2024. The $1,625.00 firm fixed-price delivery order (Contract #SPE2DB20D3103|SPE2DB24FQ2F0) is for the supply of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has an ultimate completion date of September 11, 2024 and was not set aside for any specific business classification.
Amerisourcebergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,247.79 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Emtricitabine-Tenofovir 200-300mg pharmaceuticals. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,904.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,030.97. The contract was awarded by the Defense Logistics Agency (DLA) on July 6, 2022, with a completion date of July 7, 2022. The contract is for the delivery of emtricitabine-tenofovir 200-300mg medications, a critical pharmaceutical product used in the treatment of various medical conditions. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.39 Firm Fixed Price Delivery Order (Contract #: SPE2DB20D1109|SPE2DB23FN23R) is for the delivery of Emtricitabine-Tenofovir 200-300mg medications, with a completion date of December 28, 2022. The contract does not have a set-aside designation, indicating open competition.
AmerisourceBergen holds a...